QIPT Stock Overview
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States.
Quipt Home Medical Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$6.09|
|52 Week High||CA$8.87|
|52 Week Low||CA$5.14|
|1 Month Change||3.40%|
|3 Month Change||13.62%|
|1 Year Change||-23.40%|
|3 Year Change||95.19%|
|5 Year Change||n/a|
|Change since IPO||38.41%|
Recent News & Updates
When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?
Quipt Home Medical Corp. ( CVE:QIPT ), might not be a large cap stock, but it saw a significant share price rise of...
|QIPT||CA Healthcare||CA Market|
Return vs Industry: QIPT exceeded the Canadian Healthcare industry which returned -33.7% over the past year.
Return vs Market: QIPT underperformed the Canadian Market which returned -4.1% over the past year.
|QIPT Average Weekly Movement||7.3%|
|Healthcare Industry Average Movement||8.3%|
|Market Average Movement||9.9%|
|10% most volatile stocks in CA Market||17.2%|
|10% least volatile stocks in CA Market||4.3%|
Stable Share Price: QIPT is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: QIPT's weekly volatility (7%) has been stable over the past year.
About the Company
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment.
Quipt Home Medical Fundamentals Summary
|QIPT fundamental statistics|
Is QIPT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|QIPT income statement (TTM)|
|Cost of Revenue||US$30.99m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.23|
|Net Profit Margin||6.63%|
How did QIPT perform over the long term?See historical performance and comparison
Is QIPT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 6/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for QIPT?
Other financial metrics that can be useful for relative valuation.
|What is QIPT's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does QIPT's PE Ratio compare to its peers?
|QIPT PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
Price-To-Earnings vs Peers: QIPT is good value based on its Price-To-Earnings Ratio (20.1x) compared to the peer average (54.1x).
Price to Earnings Ratio vs Industry
How does QIPT's PE Ratio compare vs other companies in the Healthcare Industry?
Price-To-Earnings vs Industry: QIPT is good value based on its Price-To-Earnings Ratio (20.1x) compared to the Canadian Healthcare industry average (36.6x)
Price to Earnings Ratio vs Fair Ratio
What is QIPT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||20.1x|
|Fair PE Ratio||30.7x|
Price-To-Earnings vs Fair Ratio: QIPT is good value based on its Price-To-Earnings Ratio (20.1x) compared to the estimated Fair Price-To-Earnings Ratio (30.7x).
Share Price vs Fair Value
What is the Fair Price of QIPT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: QIPT (CA$6.09) is trading below our estimate of fair value (CA$71.82)
Significantly Below Fair Value: QIPT is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: QIPT is good value based on its PEG Ratio (0.5x)
Discover undervalued companies
How is Quipt Home Medical forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
Future Growth Score5/6
Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: QIPT's forecast earnings growth (43.3% per year) is above the savings rate (1.6%).
Earnings vs Market: QIPT's earnings (43.3% per year) are forecast to grow faster than the Canadian market (8.3% per year).
High Growth Earnings: QIPT's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: QIPT's revenue (21.8% per year) is forecast to grow faster than the Canadian market (7.3% per year).
High Growth Revenue: QIPT's revenue (21.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if QIPT's Return on Equity is forecast to be high in 3 years time
Discover growth companies
How has Quipt Home Medical performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: QIPT has a large one-off gain of $9.3M impacting its March 31 2022 financial results.
Growing Profit Margin: QIPT became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: QIPT has become profitable over the past 5 years, growing earnings by 27.3% per year.
Accelerating Growth: QIPT has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: QIPT has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-68.2%).
Return on Equity
High ROE: QIPT's Return on Equity (12%) is considered low.
Discover strong past performing companies
How is Quipt Home Medical's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: QIPT's short term assets ($44.0M) exceed its short term liabilities ($28.5M).
Long Term Liabilities: QIPT's short term assets ($44.0M) exceed its long term liabilities ($16.3M).
Debt to Equity History and Analysis
Debt Level: QIPT has more cash than its total debt.
Reducing Debt: QIPT's debt to equity ratio has increased from 5.4% to 24% over the past 5 years.
Debt Coverage: QIPT's debt is well covered by operating cash flow (154%).
Interest Coverage: Insufficient data to determine if QIPT's interest payments on its debt are well covered by EBIT.
Discover healthy companies
What is Quipt Home Medical current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate QIPT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate QIPT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if QIPT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if QIPT's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as QIPT has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Gregory J. Crawford also known as Greg, has been President, Chief Executive Officer and Chairman of Quipt Home Medical Corp. (formerly known as Protech Home Medical Corp.) since December 21, 2017 and s...
CEO Compensation Analysis
Compensation vs Market: Greg's total compensation ($USD4.43M) is above average for companies of similar size in the Canadian market ($USD751.41K).
Compensation vs Earnings: Greg's compensation has been consistent with company performance over the past year.
Experienced Management: QIPT's management team is considered experienced (4.5 years average tenure).
Experienced Board: QIPT's board of directors are considered experienced (4.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.6%.
Quipt Home Medical Corp.'s employee growth, exchange listings and data sources
- Name: Quipt Home Medical Corp.
- Ticker: QIPT
- Exchange: TSXV
- Founded: 1993
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: CA$204.372m
- Shares outstanding: 33.56m
- Website: https://quipthomemedical.com
- Quipt Home Medical Corp.
- 1019 Town Drive
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/25 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.